2021 is 38 hours away, It will bring New BIEL Part
Post# of 7807
(Total Views: 340)
Posted On: 12/30/2020 10:18:52 AM
2021 is 38 hours away, It will bring New BIEL Partners
Followers of KW's Twitter were given advance notice of the DonJoy and KT Tape Partnerships, numerous 'Likes' for both of these companies.
There was a third company that received several 'Likes' and it had $3.2 billion in sales for 2019. This company could make the DJO and KT Deals look small by comparison.
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally.
STADA focuses on a two pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories. In financial year 2019, STADA achieved adjusted Group sales of EUR 2,608.6 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 625.5 million. Headquartered in Bad Vilbel, Germany, the main drivers of the success are the committed and highly-motivated 11,100 employees (as of December 31, 2019).
IMO STADA will be one of many new BIEL Partners in 2021 and ensure a Happy New Year for BIEL shareholders!!
Followers of KW's Twitter were given advance notice of the DonJoy and KT Tape Partnerships, numerous 'Likes' for both of these companies.
There was a third company that received several 'Likes' and it had $3.2 billion in sales for 2019. This company could make the DJO and KT Deals look small by comparison.
STADA is a leading manufacturer of high-quality pharmaceuticals. With a long-standing heritage rooted in pharmacies, we are perceived as a reliable and trustworthy partner for 125 years. With our products we help people protect and regain a dignified and able life. With our proven Generics, we ensure that everyday health remains affordable. To our employees, we offer an attractive working environment in which they can develop personally.
STADA focuses on a two pillar strategy consisting of generics, including specialty pharmaceuticals and non-prescription consumer healthcare products. Worldwide, STADA Arzneimittel AG sells its products in approximately 120 countries. Consumer Healthcare brands such as Zoflora®, Grippostad®, Snup®, Aqualor®, Vitaprost® and Nizoral® are among the top sellers in their respective product categories. In financial year 2019, STADA achieved adjusted Group sales of EUR 2,608.6 million and adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) of EUR 625.5 million. Headquartered in Bad Vilbel, Germany, the main drivers of the success are the committed and highly-motivated 11,100 employees (as of December 31, 2019).
IMO STADA will be one of many new BIEL Partners in 2021 and ensure a Happy New Year for BIEL shareholders!!
(3)
(0)BioElectronics Corporation (BIEL) Stock Research Links
Scroll down for more posts ▼